The Biospecimen Strategy Lead (BSL) is a senior manager role responsible for the strategic direction of biospecimen operations within a Therapeutic Area. This leader ensures scientific integrity and operational excellence in biospecimen plans for clinical trials, impacting patient outcomes.
The role involves significant visibility and influence, partnering with scientific and operational leaders, and representing Amgen's biospecimen strategy externally to drive innovation and capability building.